JY
ELOX

Jeff Yass’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Jeff Yass’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-303
Closed -$3K – 14646
2022
Q2 		$3K Buy
+303
New +$4.18K ﹤0.01% 12677
2021
Q4 		– Sell
-3,628
Closed -$237K – 14284
2021
Q3 		$237K Buy
3,628
+998
+38% +$61.5K ﹤0.01% 11125
2021
Q2 		$209K Buy
+2,630
New +$219K ﹤0.01% 11517

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Jeff Yass's ELOX Position: Q2 2022 in Review

Jeff Yass sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 297 shares — an estimated $4.1K sold.

Jeff Yass first reported a position in ELOX in Q3 2019 and held it in 7 quarters. The position peaked at $110K in Q4 2019. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • Jeff Yass reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Jeff Yass sold 297 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $4.1K.
  • Jeff Yass first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
  • Jeff Yass's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $110K in Q4 2019.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.